The implantation of primary AML cells can be successfully achieved by transplanting subcutaneously injected polyurethane scaffolds, ceramic scaffolds or matrix gel coated with freshly separated human bone marrow-derived MSCs in vivo (156), which proves that tumor cells or transplanted AML cells rich in CD34+ can circulate between ossicles. The gene discussed is CD34; the disease is acute myeloid leukemia.